Clover Health Investments is trading lower Tuesday afternoon after the Trump administration proposed flat MA payment rates for 2027.

Over the last six months, Clover Health’s shares have sunk to $2.60, producing a disappointing 13.5% loss - a stark contrast ...

Clover Health Investments is now a contrarian buy, with the market underestimating its path to profitability in 2026. See why I rate the CLOV stock a Buy.

Medicare Advantage (MA) insurer Clover Health is leaning on strong performance in the annual enrollment period and financial ...

Shares of health insurance company Clover Health (NASDAQ:CLOV) jumped 10% in the afternoon session after the company announced a 53% year-over-year increase in its Medicare Advantage membership and ...

Clover Health Investments Corp (NASDAQ: CLOV) stock is rising Wednesday after the company announced that it expects to achieve its first full-year GAAP net income profitability this year.

For more than 40 years, a water tank mural painted by Clover artist Todd Atkinson covered part of a building in the small ...